rss twitter facebook


RA News

Long-term Benefit of Cosentyx in Ankylosing Spondylitis

Spine Community News: Cosentyx (secukinumab) is an anti-interleukin-17A monoclonal antibody that is approved for the treatment of ankylosing spondylitis (AS).  Cosentyx is known to be effective for treating the symptoms of AS, but the duration of effectiveness remains to be determined. Doctors from North America and Europe recently reported on…

What Causes Upper Back Pain and What to do About it

Spine Community News: With low back pain afflicting 8 of 10 Americans at some point in their lives, some of us might not even know what causes its kissing cousin – upper back pain. But this equally vexing condition stems from a variety of causes that can be effectively targeted…

Osteoporosis: What You Need to Know About Current Treatment Guidelines

TheSpineCommunity NEWS: Osteoporosis (OP) is a serious illness associated with significant disability and possible mortality.  The illness is underdiagnosed in both women and men.  When a fracture is identified only a minority of patients receive appropriate therapy to prevent the next fracture. The American College of Physicians (ACP) published a…

Ask The Expert About Ankylosing Spondylitis Back Pain and other Inflammatory/Arthritic Conditions of The Spine

TheSpineCommunity Presents: Ask the Expert Series with Dr. David Borenstein TheSpineCommunity Presents: Ask the Expert Series David G. Borenstein, MD will be answering questions in TheSpineCommunity on ankylosing spondylitis (AS) and back pain the week of January 15th.   TheSpineCommunity is an online resource center and support community for individuals affected…

Start 2018 Right: Plan for Cancer Screening and Save Lives!

Screening guidelines should initiate conversations with your healthcare team.  Charles H Weaver MD, Editor CancerConnect CancerConnect News: The goal of cancer screening is to find disease at early stages in people who are otherwise asymptomatic—before it causes symptoms and when it may be more easily treatable.  Screening tests are not…

Aging Well: Your Roadmap by Decade

A decade-by-decade guide to lifelong health and wellness By Mia James R&AConnection News: There is plenty of good news these days about getting older. Take, for example, that while aging is inevitable, the decline in health, activity, and general well-being associated with advancing years is not. By making health-sustaining choices…

Winter and Back Pain – What You Need to Know!

TheSpineCommunity NEWS:  As I watched the snow falling at my front door, I knew that shoveling was in my future. I had done this task countless times since we lived in Maryland, and knew that I would have to gather up my ski pants and long underwear to be warm…

Xeljanz Effective in TNF Inhibitor Resistant Psoriatic Arthritis

R&AConnection News: According to a recent New England Journal of Medicine report, the results of a clinical trial have demonstrated that Xeljanz (tofacitinib) is effective for the treatment of active psoriatic arthritis (PsA) in patients who previously failed to respond to tumor necrosis factor inhibitor (TNFi) therapies. About Psoriatic Arthritis…

New Shingles Vaccine Available for at Risk Individuals in the US

R&AConnection News: GlaxoSmithKline has won U.S. approval for a new and improved shingles vaccine that will be marketed as Shingrix.  According to the United States Food and Drug Administration (FDA) the Shingrix vaccine has proved significantly better than the existing Zostavax vaccine in clinical trials. The FDA approved Shingrix, which…

Acupuncture Reduces Aromatase Inhibitor Joint Pain in Women with Breast Cancer

According to a well designed study presented at the 2017 San Antonio Breast Cancer Symposium acupuncture is effective in reducing pain and stiffness associated with aromatase inhibitor (AI) therapy in women with early-stage breast cancer.1 Stiffness and joint pain is a well documented concern of women undergoing AI therapy for…

Sign up for TheRAConnection Newsletter to receive the latest news, useful tips, and feature articles.

Click here to view the RAConnection past newsletters